Myc

Source: Wikipedia, the free encyclopedia.
For other uses, see MYC (disambiguation).
Chr. 8 q24.21
WikidataQ20969939
Search for
StructuresSwiss-model
DomainsInterPro
Chr. 1 p34.2
WikidataQ18029714
Search for
StructuresSwiss-model
DomainsInterPro
Chr. 2 p24.3
WikidataQ14906753
Search for
StructuresSwiss-model
DomainsInterPro

Myc is a family of

proto-oncogenes that code for transcription factors. The Myc family consists of three related human genes: c-myc (MYC), l-myc (MYCL), and n-myc (MYCN). c-myc (also sometimes referred to as MYC) was the first gene to be discovered in this family, due to homology with the viral gene v-myc
.

In

constitutively (persistently) expressed. This leads to the increased expression of many genes, some of which are involved in cell proliferation, contributing to the formation of cancer.[1] A common human translocation involving c-myc is critical to the development of most cases of Burkitt lymphoma.[2] Constitutive upregulation of Myc genes have also been observed in carcinoma of the cervix, colon, breast, lung and stomach.[1]

Myc is thus viewed as a promising target for anti-cancer drugs.

mRNA for the protein rather than via a small molecule that targets the protein itself.[4][5]

c-Myc also plays an important role in

induced pluripotent stem cells.[6]

In the

chromosome 8 and is believed to regulate expression of 15% of all genes[7] through binding on enhancer box sequences (E-boxes
).

In addition to its role as a classical transcription factor, N-myc may recruit histone acetyltransferases (HATs). This allows it to regulate global chromatin structure via histone acetylation.[8]

Discovery

The Myc family was first established after discovery of homology between an oncogene carried by the Avian virus, Myelocytomatosis (v-myc; P10395) and a human gene over-expressed in various cancers, cellular Myc (c-Myc).[citation needed] Later, discovery of further homologous genes in humans led to the addition of n-Myc and l-Myc to the family of genes.[9]

The most frequently discussed example of c-Myc as a proto-oncogene is its implication in

Burkitt's lymphoma. In Burkitt's lymphoma, cancer cells show chromosomal translocations, most commonly between chromosome 8 and chromosome 14
[t(8;14)]. This causes c-Myc to be placed downstream of the highly active immunoglobulin (Ig) promoter region, leading to overexpression of Myc.

Structure

The protein product of Myc family genes all belong to the Myc family of transcription factors, which contain

bHLH (basic helix-loop-helix) and LZ (leucine zipper) structural motifs. The bHLH motif allows Myc proteins to bind with DNA, while the leucine zipper TF-binding motif allows dimerization with Max
, another bHLH transcription factor.

Myc

5' cap
-dependent translation is inhibited, such as during viral infection.

Function

Myc proteins are

co-activator, it inhibits expression of Miz-1 target genes. In addition, myc has a direct role in the control of DNA replication.[11] This activity could contribute to DNA amplification in cancer cells.[12]

Myc is activated upon various

Shh and EGF (via the MAPK/ERK pathway).[13]
By modifying the expression of its target genes, Myc activation results in numerous biological effects. The first to be discovered was its capability to drive cell proliferation (upregulates cyclins, downregulates p21), but it also plays a very important role in regulating cell growth (upregulates ribosomal RNA and proteins), apoptosis (downregulates Bcl-2), differentiation, and stem cell self-renewal. Nucleotide metabolism genes are upregulated by Myc,[14] which are necessary for Myc induced proliferation[15] or cell growth.[16]

There have been several studies that have clearly indicated Myc's role in cell competition.[17]

A major effect of c-myc is B cell proliferation, and gain of MYC has been associated with B cell malignancies and their increased aggressiveness, including histological transformation.[18] In B cells, Myc acts as a classical oncogene by regulating a number of pro-proliferative and anti-apoptotic pathways, this also includes tuning of BCR signaling and CD40 signaling in regulation of microRNAs (miR-29, miR-150, miR-17-92).[19]

c-Myc induces MTDH(AEG-1) gene expression and in turn itself requires AEG-1 oncogene for its expression.

Myc-nick

Myc-Nick

Myc-nick is a cytoplasmic form of Myc produced by a partial proteolytic cleavage of full-length c-Myc and N-Myc.[20] Myc cleavage is mediated by the calpain family of calcium-dependent cytosolic proteases.

The cleavage of Myc by calpains is a constitutive process but is enhanced under conditions that require rapid downregulation of Myc levels, such as during terminal differentiation. Upon cleavage, the

N-terminal segment 298-residue segment remains in the cytoplasm. Myc-nick contains binding domains for histone acetyltransferases and for ubiquitin ligases
.

The functions of Myc-nick are currently under investigation, but this new Myc family member was found to regulate cell morphology, at least in part, by interacting with

myoblasts
into muscle cells.

Clinical significance

A large body of evidence shows that Myc genes and proteins are highly relevant for treating tumors.[9] Except for early response genes, Myc universally upregulates gene expression. Furthermore, the upregulation is nonlinear. Genes for which expression is already significantly upregulated in the absence of Myc are strongly boosted in the presence of Myc, whereas genes for which expression is low in the absence Myc get only a small boost when Myc is present.[6]

Inactivation of SUMO-activating enzyme (

SUMOylation may be a possible treatment for cancer.[21]

Amplification of the MYC gene was found in a significant number of epithelial ovarian cancer cases.[22] In TCGA datasets, the amplification of Myc occurs in several cancer types, including breast, colorectal, pancreatic, gastric, and uterine cancers.[23]

In the experimental transformation process of normal cells into cancer cells, the MYC gene can cooperate with the RAS gene.[24][25]

Expression of Myc is highly dependent on

BET inhibitors have been used to successfully block Myc function in pre-clinical cancer models and are currently being evaluated in clinical trials.[28]

MYC expression is controlled by a wide variety of noncoding RNAs, including

circRNA. Some of these RNAs have been shown to be specific for certain types of human tissues and tumors.[29]
Changes in the expression of such RNAs can potentially be used to develop targeted tumor therapy.

Animal models

In Drosophila Myc is encoded by the diminutive locus, (which was known to geneticists prior to 1935).[30] Classical diminutive alleles resulted in a viable animal with small body size. Drosophila has subsequently been used to implicate Myc in cell competition,[31] endoreplication,[32] and cell growth.[33]

During the discovery of Myc gene, it was realized that chromosomes that reciprocally translocate to chromosome 8 contained

IgM
heavy chain enhancer in transgenic mice gives rise to mainly lymphomas. Later on, in order to study effects of Myc in other types of cancer, transgenic mice that overexpress Myc in different tissues (liver, breast) were also made. In all these mouse models overexpression of Myc causes tumorigenesis, illustrating the potency of Myc oncogene. In a study with mice, reduced expression of Myc was shown to induce longevity, with significantly extended median and maximum lifespans in both sexes and a reduced mortality rate across all ages, better health, cancer progression was slower, better metabolism and they had smaller bodies. Also, Less TOR, AKT, S6K and other changes in energy and metabolic pathways (such as AMPK, more oxygen consumption, more body movements, etc.). The study by John M. Sedivy and others used Cre-Loxp -recombinase to knockout one copy of Myc and this resulted in a "Haplo-insufficient" genotype noted as Myc+/-. The phenotypes seen oppose the effects of normal aging and are shared with many other long-lived mouse models such as CR (calorie restriction) ames dwarf, rapamycin, metformin and resveratrol. One study found that Myc and
chronic myeloid leukaemia (CML) cells. Targeting Myc and p53 proteins with drugs gave positive results on mice with CML.[34][35]

Relationship to stem cells

Myc genes play a number of normal roles in stem cells including pluripotent stem cells. In neural stem cells, N-Myc promotes a rapidly proliferative stem cell and precursor-like state in the developing brain, while inhibiting differentiation.[36] In hematopoietic stem cells, Myc controls the balance between self-renewal and differentiation.[37] In particular, long-term hematopoietic stem cells (LT-HSCs) express low levels of c-Myc, ensuring self-renewal. Enforced expression of c-Myc in LT-HSCs promotes differentiation at the expense of self-renewal, resulting in stem cell exhaustion.[38] In pathological states and specifically in acute myeloid leukemia, oxidant stress can trigger higher levels of Myc expression that affects the behavior of leukemia stem cells.[39]

c-Myc plays a major role in the generation of

Klf4. It has since been shown that it is possible to generate iPSCs without c-Myc.[40]

Interactions

Myc has been shown to

interact
with:

Overview of signal transduction pathways involved in apoptosis.

See also

References

  1. ^ a b "Myc". NCBI.
  2. PMID 2834731
    .
  3. ^ Begley S (2013-01-09). "DNA pioneer James Watson takes aim at cancer establishments". Reuters.
  4. PMID 30597997
    .
  5. PMID 28643779
    .
  6. ^
    PMID 23021216
    .
  7. PMID 17928593
    .
  8. PMID 19047142
    .
  9. ^
    doi:10.1146/annurev-cancerbio-030518-055826
    .
  10. PMID 24384817
    .
  11. S2CID 4422771
    .
  12. PMID 1886715
    .
  13. S2CID 29661004
    .
  14. PMID 18628958
    .
  15. PMID 18677108
    .
  16. PMID 26889675
    .
  17. S2CID 4414411
    .
  18. PMID 11163229
    .
  19. PMID 18423194
    .
  20. PMID 20691906
    .
  21. PMID 22157079
    .
  22. PMID 23791828
    .
  23. PMID 24874471
    .
  24. S2CID 2338865
    .
  25. S2CID 2972931
    .
  26. PMID 24466310
    .
  27. PMID 24905006
    .
  28. PMID 21889194
    .
  29. PMID 34440124
    .
  30. PMID 17246888
    .
  31. S2CID 18357397
    .
  32. S2CID 721144
    .
  33. S2CID 5215149. Archived from the original
    (PDF) on 2022-04-03. Retrieved 2020-03-20.
  34. PMID 27281222
    .
  35. ^ "Scientists identify drugs to target 'Achilles heel' of Chronic Myeloid Leukaemia cells". myScience. 2016-06-08. Archived from the original on 2018-07-27. Retrieved 2016-06-09.
  36. PMID 12381668
    .
  37. PMID 15545632
    .
  38. PMID 15545632
    .
  39. PMID 38201575
    .
  40. S2CID 7593915
    .
  41. ^
    PMID 11839798
    .
  42. ^
    PMID 11916966
    .
  43. PMID 14612409
    .
  44. PMID 12646176
    .
  45. S2CID 30771256
    .
  46. ^
    PMID 15210690
    .
  47. S2CID 29519364
    .
  48. PMID 25452129
    .
  49. PMID 15616584
    .
  50. ^
    S2CID 15634637
    .
  51. S2CID 4354157
    .
  52. PMID 12776177
    .
  53. PMID 18066065
    .
  54. PMID 17877811
    .
  55. PMID 15769738
    .
  56. S2CID 45404088
    .
  57. PMID 9207092
    .
  58. PMID 10551811
    .
  59. ^
    PMID 17353931
    .
  60. ^
    PMID 10611234
    .
  61. ^
    S2CID 17693834
    .
  62. ^
    S2CID 12945791
    .
  63. ^
    PMID 12584560
    .
  64. PMID 2006410
    .
  65. PMID 12391307
    .
  66. PMID 10593926
    .
  67. S2CID 30576019
    .
  68. PMID 9184233
    .
  69. S2CID 16142388
    .
  70. PMID 10229200
    .
  71. S2CID 17891130
    .
  72. PMID 9689053
    .
  73. S2CID 41886122
    .
  74. PMID 11282029
    .
  75. PMID 10446203
    .
  76. PMID 12080043
    .
  77. ^
    PMID 12660246
    .
  78. PMID 9792694
    .
  79. PMID 11567024
    .
  80. ^
    PMID 11804592
    .
  81. PMID 12446731
    .
  82. PMID 7729426
    .
  83. PMID 25818646
    .
  84. PMID 8266081
    .
  85. S2CID 12696178
    .
  86. PMID 9312026
    .
  87. ^ "PSICQUIC View". ebi.ac.uk. Retrieved 2019-05-02.

Further reading

External links
Retrieved from "https://en.wikipedia.org/w/index.php?title=Myc&oldid=1213479582"
This page is based on the copyrighted Wikipedia article: Myc. Articles is available under the CC BY-SA 3.0 license; additional terms may apply.Privacy Policy